Natukunda Julian, Kirabira Peter, Ong Ken Ing Cherng, Shibanuma Akira, Jimba Masamine
1Public Health and Management, Institute of Health, International Health Sciences University, Kampala, Uganda.
2Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Trop Med Health. 2019 Jan 17;47:8. doi: 10.1186/s41182-019-0135-z. eCollection 2019.
Adolescents living with human immunodeficiency virus (HIV) die owing to acquired immune deficiency syndrome (AIDS)-related causes more than adults. Although viral suppression protects people living with HIV from AIDS-related illnesses, little is known about viral outcomes of adolescents in sub-Saharan Africa where the biggest burden of deaths is experienced. This study aimed to identify the factors associated with viral load suppression among HIV-positive adolescents (10-19 years) receiving antiretroviral therapy (ART) in Uganda.
We conducted a cross-sectional study among school-going, HIV-positive adolescents on ART from August to September 2016. We recruited 238 adolescents who underwent ART at a public health facility and had at least one viral load result recorded in their medical records since 2015. We collected the data of patients' demographics and treatment- and clinic-related factors using existing medical records and questionnaire-guided face-to-face interviews. For outcome variables, we defined viral suppression as < 1000 copies/mL. We used multivariate logistic regression to determine factors associated with viral suppression.
We analyzed the data of 200 adolescents meeting the inclusion criteria. Viral suppression was high among adolescents with good adherence > 95% (adjusted odds ratio [AOR] 2.73, 95% confidence interval [95% CI, 1.09 to 6.82). However, 71% of all adolescents who did not achieve viral suppression were also sufficiently adherent (adherence > 95%). Regardless of adherence status, other risk factors for viral suppression at the multivariate level included having a history of treatment failure (AOR 0.26, 95% CI, 0.09 to 0.77), religion (being Anglican [AOR 0.19, 95% CI, 0.06 to 0.62] or Muslim [AOR 0.17, 95% CI, 0.05 to 0.55]), and having been prayed for (AOR 0.38, 95% CI, 0.15 to 0.96).
More than 70% of adolescents who experienced virologic failure were sufficiently adherent (adherence > 95). Adolescents who had unsuppressed viral loads in their initial viral load were more likely to experience virologic failure upon a repeat viral load regardless of their adherence level or change of regimen. The study also shows that strong religious beliefs exist among adolescents. Healthcare provider training in psychological counseling, regular and strict monitoring of adolescent outcomes should be prioritized to facilitate early identification and management of drug resistance through timely switching of treatment regimens to more robust combinations.
感染人类免疫缺陷病毒(HIV)的青少年因获得性免疫缺陷综合征(AIDS)相关原因死亡的人数多于成年人。尽管病毒抑制可保护HIV感染者免受AIDS相关疾病的侵害,但对于撒哈拉以南非洲地区青少年的病毒感染情况知之甚少,该地区是死亡负担最重的地区。本研究旨在确定乌干达接受抗逆转录病毒治疗(ART)的HIV阳性青少年(10 - 19岁)中与病毒载量抑制相关的因素。
2016年8月至9月,我们对接受ART的在校HIV阳性青少年进行了一项横断面研究。我们招募了238名在公共卫生机构接受ART治疗且自2015年以来其病历中至少记录有一次病毒载量结果的青少年。我们使用现有的病历和问卷引导的面对面访谈收集了患者的人口统计学数据以及与治疗和诊所相关的因素。对于结局变量,我们将病毒抑制定义为<1000拷贝/毫升。我们使用多因素逻辑回归来确定与病毒抑制相关的因素。
我们分析了200名符合纳入标准的青少年的数据。依从性良好(>95%)的青少年病毒抑制率较高(调整后的优势比[AOR]为2.73,95%置信区间[95%CI,1.09至6.82])。然而,在所有未实现病毒抑制的青少年中,71%的人依从性也足够好(依从性>95%)。在多因素分析层面,无论依从性状况如何,病毒抑制的其他风险因素包括有治疗失败史(AOR为0.26,95%CI,0.09至0.77)、宗教信仰(圣公会教徒[AOR为0.19,95%CI,0.06至0.62]或穆斯林[AOR为0.17,95%CI,0.05至0.55])以及曾接受祈祷(AOR为0.38,95%CI,0.15至0.96)。
超过70%经历病毒学失败的青少年依从性足够好(依从性>95%)。初始病毒载量未被抑制的青少年,无论其依从水平或治疗方案是否改变,再次进行病毒载量检测时更有可能经历病毒学失败。该研究还表明青少年中存在强烈的宗教信仰。应优先对医疗服务提供者进行心理咨询培训,并定期严格监测青少年的治疗结果,以便通过及时更换为更有效的治疗方案组合来促进耐药性的早期识别和管理。